Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guo-Fang Hu

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Oncotargets and Therapy|August 10, 2017
The status of immunosuppression in patients with stage IIIB or IV non-small-cell lung cancer correlates with the clinical characteristics and response to chemotherapyYuan Wang, Guo-Fang Hu, Zhe-Hai Wang
Annals of Translational Medicine|March 14, 2022
Constructing a competing endogenous RNA network for osteoarthritisShu-Liang Hua, Jun-Qing Liang, Guo-Fang Hu, et al.
Drug Design, Development and Therapy|July 1, 2016
Efficacy and safety of gemcitabine plus erlotinib for locally advanced or metastatic pancreatic cancer: a systematic review and meta-analysisYuan Wang, Guo-Fang Hu, Qian-Qian Zhang, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Oncotargets and Therapy|August 10, 2017
The status of immunosuppression in patients with stage IIIB or IV non-small-cell lung cancer correlates with the clinical characteristics and response to chemotherapyYuan Wang, Guo-Fang Hu, Zhe-Hai Wang
Annals of Translational Medicine|March 14, 2022
Constructing a competing endogenous RNA network for osteoarthritisShu-Liang Hua, Jun-Qing Liang, Guo-Fang Hu, et al.
Drug Design, Development and Therapy|July 1, 2016
Efficacy and safety of gemcitabine plus erlotinib for locally advanced or metastatic pancreatic cancer: a systematic review and meta-analysisYuan Wang, Guo-Fang Hu, Qian-Qian Zhang, et al.
Pageof 1